Total CAG Diagnostics recurring revenue — Total Revenue
Idexx Laboratories Total CAG Diagnostics recurring revenue — Total Revenue increased by 8.3% to $920.31M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.1%, from $806.27M to $920.31M. Over 4 years (FY 2021 to FY 2025), Total CAG Diagnostics recurring revenue — Total Revenue shows an upward trend with a 7.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates a higher reliance on predictable, high-margin recurring revenue streams, which typically enhances valuation multiples and business stability. A decrease may suggest a shift toward one-time equipment sales or increased competitive pressure on core diagnostic services.
Detailed definition
This metric represents the portion of total revenue derived from recurring diagnostic products and services within the C...
Peer comparison
Peers in the veterinary or human diagnostics space often report this as 'consumables' or 'recurring revenue' percentage, typically benchmarking against high-growth medical device companies with razor-and-blade business models.
idxx_segment_total_cag_diagnostics_recurring_revenue_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $633.64M | $633.64M | $633.64M | $665.07M | $665.07M | $665.07M | $665.07M | $726.90M | $762.48M | $733.96M | $712.09M | $780.14M | $808.45M | $783.44M | $757.45M | $806.27M | $878.00M | $873.27M | $849.66M | $920.31M |
| QoQ Change | — | +0.0% | +0.0% | +5.0% | +0.0% | +0.0% | +0.0% | +9.3% | +4.9% | -3.7% | -3.0% | +9.6% | +3.6% | -3.1% | -3.3% | +6.4% | +8.9% | -0.5% | -2.7% | +8.3% |
| YoY Change | — | — | — | — | +5.0% | +5.0% | +5.0% | +9.3% | +14.6% | +10.4% | +7.1% | +7.3% | +6.0% | +6.7% | +6.4% | +3.3% | +8.6% | +11.5% | +12.2% | +14.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's total cag diagnostics recurring revenue — total revenue?
- Idexx Laboratories (IDXX) reported total cag diagnostics recurring revenue — total revenue of $920.31M in Q1 2026.
- How has Idexx Laboratories's total cag diagnostics recurring revenue — total revenue changed year-over-year?
- Idexx Laboratories's total cag diagnostics recurring revenue — total revenue increased by 14.1% year-over-year, from $806.27M to $920.31M.
- What is the long-term trend for Idexx Laboratories's total cag diagnostics recurring revenue — total revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's total cag diagnostics recurring revenue — total revenue has grown at a 7.7% compound annual growth rate (CAGR), from $2.53B to $3.41B.
- What does total cag diagnostics recurring revenue — total revenue mean?
- The percentage of total company revenue generated from ongoing, repeatable diagnostic sales and services within the companion animal segment.